Comparative analysis of clinical efficacy and safety of Plavix and aspirin in the treatment of coronary heart disease

Minerva Surg. 2024 Apr;79(2):234-236. doi: 10.23736/S2724-5691.22.09527-2. Epub 2022 Mar 10.

Authors

Mingqiu Wu¹, Yehong Zhang², Changbao Hu³

Affiliations

¹ Department of Cardiology, Changxing County People's Hospital, Huzhou, China.
² EICU, Changxing County People's Hospital, Huzhou, China.
³ Department of Cardiology, Changxing County People's Hospital, Huzhou, China - 1714571746@qq.com.

PMID: 35266681
DOI: 10.23736/S2724-5691.22.09527-2

No abstract available

MeSH terms

Aspirin* / adverse effects
Clopidogrel / adverse effects
Coronary Disease* / drug therapy
Humans
Platelet Aggregation Inhibitors / adverse effects
Treatment Outcome

Substances

Clopidogrel
Aspirin
Platelet Aggregation Inhibitors